• Mon, August 12, 2024
Mitchell Kapoor Reiterated (VERV) at Strong Buy and Held Target at $15 on, Aug 12th, 2024
Mitchell Kapoor of HC Wainwright & Co., Reiterated "Verve Therapeutics, Inc." (VERV) at Strong Buy and Held Target at $15 on, Aug 12th, 2024.
Mitchell has made no other calls on VERV in the last 4 months.
There is 1 other peer that has a rating on VERV. Out of the 1 peers that are also analyzing VERV, 0 agree with Mitchell's Rating of Hold.
This is the rating of the analyst that currently disagrees with Mitchell
- Luca Issi of "RBC Capital" Maintained at Buy with Decreased Target to $20 on, Friday, August 9th, 2024
Like: 👍
